Cargando…
Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors
INTRODUCTION: Biomarkers indicating trait, progression and prediction of pathology and symptoms in Parkinson's disease (PD) often lack specificity or reliability. Investigating biomarker variance between individuals and over time and the effect of confounding factors is essential for the evalua...
Autores principales: | Bernhard, Felix P., Heinzel, Sebastian, Binder, Gerhard, Weber, Karin, Apel, Anja, Roeben, Benjamin, Deuschle, Christian, Maechtel, Mirjam, Heger, Tanja, Nussbaum, Susanne, Gasser, Thomas, Maetzler, Walter, Berg, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788352/ https://www.ncbi.nlm.nih.gov/pubmed/26967642 http://dx.doi.org/10.1371/journal.pone.0150552 |
Ejemplares similares
-
Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
por: Hobert, Markus A., et al.
Publicado: (2019) -
Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
por: Heinzel, Sebastian, et al.
Publicado: (2014) -
Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson’s Disease Patients and Controls
por: Maetzler, Walter, et al.
Publicado: (2014) -
GH Responsiveness Is not Correlated to IGF1 P2 Promoter Methylation in Children With Turner Syndrome, GHD and SGA Short Stature
por: Apel, Anja, et al.
Publicado: (2022) -
Corrigendum: GH responsiveness is not correlated to IGF1 P2 promoter methylation in children with Turner syndrome, GHD and SGA short stature
por: Apel, Anja, et al.
Publicado: (2022)